Krystal Biotech: TD Cowen cuts target price to $380 from $403
KRYS•TD Cowen cut its target price for Krystal Biotech to $380 from $403.
Related News
T. Rowe Price Group price objective raised to $93 from $90
TROW•
Cboe Global Markets price objective raised to $350 from $329
CBOE•
Philips beats quarterly profit estimates on higher sales, gross margin
PHG•
Sirius XM Holdings target price cut to $32 from $34
SIRI•
HII, Thales demonstrate autonomous mine countermeasure capability
HII•